Just Other Articles - Internet and Businesses Online

With all the recent interest in Web analytics, it seems as though new companies are emerging every day. One of the most exciting new providers is VisiStat, a San Jose, California-based startup that is redefining how people use Web reporting.

I sat down with Stephen Oachs, founder of VisiStat (www.visistat.com), to talk about the future of

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

Web analytics, as well as the newly released VisiStat 4.0.

Q. Stephen, what Web analytics market trends have you seen so far this year?

A. Well, after a bit of a rocky start, the Google acquisition of Urchin and the subsequent release of Google Analytics have created a seismic event in the market. Some of the legacy Web analytics

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

companies that previously offered expensive enterprise reporting packages are now faced with a very serious competitor. Google is essentially giving the very same service away free.

Don’t get me wrong; all of this is good news for companies like VisiStat that have earned their stripes by toughing it out at the low end of the market, especi

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

lly where education is a big factor in customer acquisition and retention. And Google, with their fine-tuned marketing machine, has generated a ton of interest in the Web reporting space. People who didn’t even know they needed Web reporting are now demanding it. What you have to consider is, Google has everything to gain by offering Web an

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

lytics, as they are in the business to sell Pay Per Click ads – but I see it a bit like asking the fox to watch the hen house.

Q. Are you at all concerned about competing in the Web analytics market with titans like Google and WebTrends?

A. Not at all. We let these big players do the hard work of demand creation -- educating peop

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e about why Web analytics is so important. Meanwhile, we focus on delivering a valuable service to small- and medium-sized businesses in a way they can use and understand. It’s pretty obvious that if the users don’t comprehend their reports, they miss the full business benefits. And remember, unlike these other companies, VisiStat has alway

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

been focused on one thing – providing rich data as fast as humanly possible, in an easy-to-digest format. From a feature point of view, we provide many unique capabilities, like our exclusive StatCasting™, AdCaM™ and PageAlarm™ technology. These are things that even Google doesn’t have yet.

Q. How does VisiStat stack up against enterp

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ise solutions?

A. It’s really apples and oranges. Enterprise solutions address a much different business model, and are tailored toward larger companies with educated staff to interpret the information they provide. VisiStat takes a much different approach, both in the data we provide and the means in which we deliver. VisiStat is ver

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

much suited for the small to medium business, where often times our customers are single business owners, or only have small staff, thus they do not have the time to become educated to use an enterprise solution, nor can they reasonably afford one.

Some extremely robust enterprise Web analytic products on the market provide very granular

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

nformation. These services are perfect for the fortune 1000-type companies. VisiStat’s mission is to service the rest of the market. There were 18 million new domains registered in 2005 and the small business opportunity on the Internet grows every day. We seek to service those customers, which isn’t to say we can’t provide analytics for la

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ger companies – we actually work with many large companies and they love the information VisiStat provides. But our focus is strongly on the small business community.

I guess the best way to sum it up is that Web analytics is not a "one-size-fits all" service, therefore, we provide VisiStat Web Analytics side by side with other tracking se

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

rvices. For instance, a marketing group may use VisiStat to monitor visitor traffic, page usage, search engine keyword usage, pay per click campaigns, etc., and the IT people may keep WebTrends in place as it provides excellent information about network and bandwidth usage, dead pages and bots and crawler usage. VisiStat actually complement

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

any other analytics services, allowing all departments in a business to get exactly the information needed for their specific uses.

Q. VisiStat just released VisiStat 4.0. What are the new capabilities associated with the release of this version?

A. Well first, VisiStat 4.0 unveils unique features offered nowhere else, such as W

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

rldMaps, which is a kind of a GPS for Website monitoring. With WorldMaps, users can see the source and volume of visits to their Website from any country around the globe. Second, our users asked us to respond to the dramatic increase in online advertising and e-mail campaigns. So VisiStat 4.0 now offers LinkTracker, a new feature that disp

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ays the number of document downloads and other clickable actions available on every page of a Website.

We’ve also added some security features like Domain Filtering, which uses data authentication to prevent "spoofing," a simple yet insidious trick where hackers simply copy a site's HTML page code and post their own look-alike site. The re

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

aining new features in VisiStat 4.0 are designed to improve the user experience. Friendly Page Naming lets you create and track easy-to-remember page names instead of clumsy URL page descriptors, and QuickNav, a handy little toggle window, lets you jump directly to the VisiStat report you need, when you need it.

Q. Finally, can you off

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

r some insight into where you see the Web Analytics market is headed?

A. I think I can sum it up by saying that there is a vast untapped market that is just beginning to realize the benefits of Web analytics. The Internet continues to evolve – I remember when you had to convince someone why they needed a Website, then why they needed

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

o be listed well in Search Engines, then why they needed their site to function and be a tool; and now this is all common place and businesses are realizing they need to know what’s happening on their indispensable Websites. They are starting to treat their online businesses just as they would a brick and mortar, where concepts such as retu

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

n on investment has been an online mystery.

I think this market will continue to become commoditized. Businesses will require easy to use, real-time information, critical for their online success. The other trend I see is moving away from log-based, time-delayed reports and toward real-time, "as-it-happens" Web reporting. That’s a concept

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e refer to as “information at the speed of business™” and represents a shift in the Internet to Software as a Service (Web 2.0), where Websites perform and operate like their desktop software cousins, but with vast advantages for the consumer.

Q. Stephen, thanks for taking the time to speak with us today.

A. It’s been my pleasure

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/86730/justotherarticles-QA-With-Stephen-Oachs-Technical-Director-of-VisiStat--Web-Analytics-Trends-Discussed.html">Q&A With Stephen Oachs, Technical Director of VisiStat - Web Analytics Trends Discussed</a>

BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/86730/justotherarticles-QA-With-Stephen-Oachs-Technical-Director-of-VisiStat--Web-Analytics-Trends-Discussed.html]Q&A With Stephen Oachs, Technical Director of VisiStat - Web Analytics Trends Discussed[/url]

The Motor Carrier Act of 1980 set new standards in trucking industry. Before the legislation, licenses had only 18,000 truckers and by 1990, this number increased to 45,500. First only a half of carriers had a right to move freight freely within 48 states and in 1990 – 20,000.

During times of disaster it's important to recognize that there are just as many heroes behind the scenes as there are in the media spotlight. Consider how all the relief efforts would be progressing without a simple common element: packaging. Whether it's bottled water or MRE's (meals ready to eat), it is the packaging that make rescue/relief efforts this achievable.

The easiest way to acquire an email list for your ezine or email marketing is just to buy one. They're not too expensive, and they provide you with a long list of names and email addresses. But if t...

Tags

Links

Just Other Articles - Q&A With Stephen Oachs, Technical Director of VisiStat - Web Analytics Trends Discussed

Related Articles: